Antituberculous effect of some imidazole derivatives. 1978

M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses

Related Publications

M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
January 1968, Farmakologiia i toksikologiia,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
August 2004, Bioorganic & medicinal chemistry letters,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
June 1964, The Journal of pharmacy and pharmacology,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
January 1967, Mikrobiolohichnyi zhurnal,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
October 1968, The South African journal of medical sciences,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
May 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
January 1960, Annales pharmaceutiques francaises,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
January 1987, Psychopharmacology,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
July 1964, The Journal of pharmacy and pharmacology,
M M Abdel Kader, and K M Suleiman, and S A Elian, and S Shouab, and B A El-Moursi, and F Halawa
June 1967, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
Copied contents to your clipboard!